Amphastar: Higher Costs, Lower Growth, And A 'Value Trap' Label
Source: SeekingAlpha
2026-02-28 08:25:00 ET
Overview
My December 2025 evaluation of Amphastar Pharmaceuticals ( AMPH ) has come full circle after the company reported its Q4 earnings and FY26 expectations on Thursday....
Read the full article on Seeking Alpha
For further details see:
Amphastar: Higher Costs, Lower Growth, And A 'Value Trap' Label
Amphastar Pharmaceuticals Inc.
NASDAQ: AMPH
AMPH Trading
-8.96% G/L:
$17.07 Last:
198,575 Volume:
$18.575 Open:
AMPH Latest News
February 26, 2026 04:05:00 pm
Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full Year Ended December 31, 2025
AMPH Stock Data
$1,321,584,524
33,315,326
0.46%
98
N/A
Pharmaceuticals
Healthcare
US
Rancho Cucamonga
